Oklahoma 2022 2022 Regular Session

Oklahoma Senate Bill SB136 Amended / Bill

Filed 03/31/2021

                     
 
SB136 HFLR 	Page 1 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
HOUSE OF REPRESENTATIVES - FLOOR VERSION 
 
STATE OF OKLAHOMA 
 
1st Session of the 58th Legislature (2021) 
 
ENGROSSED SENATE 
BILL NO. 136 	By: Simpson of the Senate 
 
  and 
 
  Roe of the House 
 
 
 
 
An Act relating to breast and cervical cancer; 
amending 63 O.S. 2011, Section 1-556, as amended by 
Section 55, Chapter 229, O.S.L. 2013 (63 O.S. Supp. 
2020, Section 1-556), which relates to annual report; 
modifying time period of report; modifying criteria; 
updating statutory references and language; and 
providing an effective date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2011, Section 1 -556, as 
amended by Section 55, Chapter 229, O.S.L. 2013 (63 O.S. Supp. 2020, 
Section 1-556), is amended to re ad as follows: 
Section 1-556.  A.  The State Department of Health, giving 
consideration to the recommendations of the Advancement of Wellness 
Advisory Council created in Section 44 of this act Section 1-103a.1 
of this title, shall be responsible for evalua ting and reporting to 
the Governor and the State Commissioner of Health regarding   
 
SB136 HFLR 	Page 2 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
contracting for statewide services or issues related to breast 
cancer including, but not limited to: 
1.  Mammography and pap smear screening of women for breast and 
cervical cancer as an early detection health care measure , provided 
by facilities which are accredited by national organizations that 
have formed coalitions to issue national cancer screening 
guidelines; 
2.  Medical referral of screened persons with abnormal breast 
findings and, to the extent practical, for additional services or 
assistance for such persons; 
3.  Education and training programs for health care 
professionals to improve methods for the detection and control of 
breast and cervical cancer, and to improve communication with breast 
and cervical cancer patients after diagnosis; 
4.  Annual public education and awareness campaigns to improve 
the knowledge and health care practices of all Oklahomans with 
respect to breast and cervical cancer; 
5.  Epidemiological trend studies utilizing the data from the 
Oklahoma Central Cancer Registry for incidence, prevalence and 
survival of breast and cervical cancer victims; and 
6.  Outreach to groups with high proportions of uninsured and 
underinsured women. 
B.  The evaluative efforts of the Advisory Committee with 
respect to contracts for services specified in subsection A of this   
 
SB136 HFLR 	Page 3 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
section shall provide appropriate oversight and requirements that 
result in: 
1.  Enhanced quality control standards within facilities which 
perform diagnostic cancer screening for breast and cervical cancer; 
and 
2.  Establishment of a fee schedule for breast and cervical 
cancer screening and diagnosis that complies with accepted 
Medicare/Medicaid rates and that incorporates a sliding fee payment 
system to encourage self -responsibility. 
C.  The State Department of Health, giving consideration to the 
recommendations of the Advancement of Wellness Advisory Council 
created in Section 44 of this act Section 1-103a.1 of this title , 
shall report annually to the Governor, the Speaker of the House of 
Representatives, the President Pro Tempore of the Senate, and the 
State Board Commissioner of Health by October 1 of each year every 
fifth year, beginning on October 1, 2021 , activities completed 
pursuant to the Oklahoma Breast and Cervical Cancer Act during the 
prior five (5) fiscal year, years including a report of the funding 
for revolving funds expended on related activities.  The report 
shall may identify populations at highest risk for breast or 
cervical cancer, priority strategies, and emerging technologies , 
including newly introduced therapies and preventive vaccines that 
are effective in preventing and controlling the risk of breast and 
cervical cancer, and any recommendations for additional funding, if   
 
SB136 HFLR 	Page 4 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
necessary, to provide screenings and treatment for breast and 
cervical cancer for uninsured and underinsured women.  The report 
shall may further recommend strategies or actions to reduce the 
costs of breast and cervical cancer in the State of Oklahoma this 
state. 
D.  The Advancement of Wellness Advisory Council shall evaluate 
the prospective termination or continuation of its ongoing duties on 
October 1, 2008.  Such evaluation shall be made based on the 
successful implementation of breast and cervical cancer reduction 
plans and/or achievement of significant reductions in breast and 
cervical cancer morbidity and mortality in the State of Oklahoma 
this state. 
SECTION 2.  This act shall become effective October 1, 2021. 
 
COMMITTEE REPORT BY: COMM ITTEE ON PUBLIC HEALTH, dated 03/31/2021 - 
DO PASS.